Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 817 clinical trials
featured
Colorectal cancer screening in African American women

Researchers at the University of Kentucky are inviting you to participate in a survey-based study to assess beliefs and behaviors about colorectal cancer screening.  

  • 56 views
  • 23 Nov, 2020
  • 1 location
featured
Have you ever been diagnosed with colon cancer?

Researchers at the University of Kentucky are conducting a study to learn about the difficulties and obstacles people face in obtaining surgical care for their cancer. Researchers hope that by understanding the challenges you face, they can implement future changes to prevent others from having to face the same obstacles. …

  • 15 views
  • 23 Nov, 2020
  • 1 location
featured
Biofilm Epidemiology and Mechanisms in Colon Cancer

Biofilm Epidemiology and Mechanisms in Colon Cancer

  • 128 views
  • 23 Nov, 2020
  • 1 location
featured
What if there were a simpler way to find colorectal cancer?

ECLIPSE is being done to find out if a simple blood test can find early signs of colorectal cancer. Colorectal cancer is the #2 cause of death among adults with cancer, but it doesn’t have to be.  If found early, it’s one of the most preventable and treatable cancers.  NOW …

  • 13 views
  • 23 Nov, 2020
  • 1 location
featured
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

A study to evaluate a blood test to detect colorectal cancer in patients going for screening colonoscopies.

cancer screening
colorectal cancers
colorectal cancer screening
colon cancer screening
colon cancer
  • 19 views
  • 14 Jan, 2021
  • 1 location
featured
CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.

CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.

  • 124 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 1/2 Trial of MRTX849 in Combination with TNO155 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

Characterize the safety and tolerability, and evaluate Pharmacokinetics of MRTX849 in combination with TNO155 in patients with advanced solid tumor malignancies with KRAS G12C mutation. MRTX849 is an orally available small molecute inhibitor of KRASG12C. TNO155 is a selective, orally bioavailable allosteric inhibitor of wild type SHP2.

advanced solid tumor
solid tumor
malignant solid tumor
solid tumors
  • 114 views
  • 08 Dec, 2020
  • 4 locations
featured
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation

Evaluates the safety, tolerability, pharmacokinetics, metabolites, pharmacodynamics, and clinical activity of MRTX849 in patients with advanced solid tumors with a KRAS G12C mutation. MRTX849 is an orally-available small molecule inhibitor of KRAS G12C.

advanced solid tumor
solid tumor
malignant solid tumor
  • 405 views
  • 16 Dec, 2020
  • 63 locations
featured
A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy

A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy

  • 178 views
  • 08 Nov, 2020
  • 1 location
featured
Triple IN Study (Inhibition of Incisional Infections): Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections among Colorectal Surgery Patients

Triple IN Study (Inhibition of Incisional Infections): Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections among Colorectal Surgery Patients

  • 110 views
  • 08 Nov, 2020
  • 1 location